Probucol Treatment Decreases Serum Concentrations of Diet-Derived Antioxidants
- 1 August 1995
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (8), 1057-1063
- https://doi.org/10.1161/01.atv.15.8.1057
Abstract
Abstract The effect of probucol, which is both a cholesterol-lowering drug and an antioxidant, on the serum concentrations of diet-derived antioxidants vitamin E, β-carotene, lycopene, and vitamin A was studied in 303 hypercholesterolemic subjects. In a 3-year, double-blind, randomized trial we investigated to determine whether combined treatment with diet, cholestyramine, and probucol could reduce the progression of femoral atherosclerosis. Serum and lipoprotein antioxidant levels were measured by reverse-phase high-performance liquid chromatography. Cholestyramine significantly lowered serum concentrations of vitamin E by 7%, β-carotene by 40%, and lycopene by 30% (all P <.001) due to impairment of gastrointestinal absorption and to serum cholesterol lowering. Probucol reduced serum vitamin E by 14% ( P <.001) secondary to cholesterol and triglyceride lowering. The carotenoids were reduced by probucol by 30% to 40% ( P <.001) most probably due to reductions in lipoprotein particle size and to competition with these substances for incorporation into VLDL during its assembly in the liver. This study shows that the use of a lipid-soluble antioxidant and cholesterol-lowering drug may have unfavorable effects on blood levels of diet-derived antioxidants.Keywords
This publication has 18 references indexed in Scilit:
- The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1994
- Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteersAtherosclerosis, 1992
- Probucol reduces plasma lipid peroxides in manAtherosclerosis, 1992
- Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit — long-term antiatherogenic effect and effects on established plaquesAtherosclerosis, 1992
- Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transferAtherosclerosis, 1990
- Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitroAtherosclerosis, 1990
- Beyond CholesterolNew England Journal of Medicine, 1989
- Effect of particle size and lipid composition of bovine blood high density lipoprotein on its function as a carrier of β-caroteneBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- The effect of cholestyramine on intestinal absorption.Gut, 1975
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJCI Insight, 1955